WallStreetZenWallStreetZen

NASDAQ: ACRS
Aclaris Therapeutics Inc Stock Ownership - Who owns Aclaris Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aclaris Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Neal WalkerCEO2025-04-013,042$1.48
$4.50kSell
Joseph MonahanChief Scientific Officer2025-03-0127,258$1.99
$54.24kSell
Kevin BalthaserChief Financial Officer2025-03-01727$1.99
$1.45kSell
Neal WalkerCEO2025-03-013,277$1.99
$6.52kSell
Joseph MonahanChief Scientific Officer2025-02-0111,317$2.48
$28.07kSell
Kevin BalthaserChief Financial Officer2025-02-015,816$2.48
$14.42kSell
Neal WalkerINTERIM CEO2025-02-013,559$2.48
$8.83kSell
James LoeropChief Business Officer2025-02-0115,447$2.48
$38.31kSell
Neal WalkerINTERIM CEO2025-01-0213,532$2.48
$33.56kSell
James LoeropChief Business Officer2025-01-028,575$2.48
$21.27kSell

1 of 5

ACRS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACRS insiders and whales buy or sell their stock.

ACRS Shareholders

What type of owners hold Aclaris Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Braden Michael Leonard26.22%28,293,975$32.26MInsider
Bml Capital Management LLC13.20%14,250,000$16.25MInstitution
Adage Capital Partners GP LLC8.92%9,627,304$10.98MInstitution
Vivo Capital LLC8.24%8,888,888$10.13MInstitution
Fmr LLC8.00%8,637,727$9.85MInsider
Rock Springs Capital Management LP5.75%6,204,309$7.07MInstitution
Ra Capital Management LP4.32%4,666,667$5.32MInstitution
Ra Capital Management LP4.02%4,339,299$4.95MInsider
Vanguard Group Inc4.01%4,325,263$4.93MInstitution
Albert Cha3.88%4,191,397$4.78MInsider

1 of 3

ACRS vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACRS57.60%42.40%Net BuyingNet Selling
SERA48.07%25.83%Net SellingNet Selling
OCX9.32%90.68%Net BuyingNet Buying
FONR47.25%3.58%
XGN33.76%62.41%Net SellingNet Selling
View Top Diagnostic & Research Stocks

Aclaris Therapeutics Stock Ownership FAQ

Who owns Aclaris Therapeutics?

Aclaris Therapeutics (NASDAQ: ACRS) is owned by 81.07% institutional shareholders, 59.67% Aclaris Therapeutics insiders, and 0.00% retail investors. Braden Michael Leonard is the largest individual Aclaris Therapeutics shareholder, owning 28.29M shares representing 26.22% of the company. Braden Michael Leonard's Aclaris Therapeutics shares are currently valued at $31.97M.

If you're new to stock investing, here's how to buy Aclaris Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.